The risk of dyspnea or arrhythmia development was assessed via multivariate analysis with respect to SOD2, GPX1, GPX3 and Nrf2 genotypes (Figure 1 and Figure 2, respectively). This evidence concerns the gene NFE2L2 and cardiac arrhythmia.